Last reviewed · How we verify

NCT03443141

Effect of Vitamin E-containing Dressing on Surgical Site Infection in Colorectal Surgery

Status unknown Phase 3 Last updated 22 February 2018
What this trial tests

Phase 3 trial testing Vitamin E in Surgical Site Infection in 120 participants. Status unknown.

Timeline
1 January 2018
Primary endpoint
30 March 2018
30 March 2018

Quick facts

Lead sponsorHospital General Universitario Elche
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment120
Start date1 January 2018
Primary completion30 March 2018
Estimated completion30 March 2018
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital General Universitario Elche

Who can join

Eligibility, any sex, with Surgical Site Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, randomized study will be performed. Patients are randomized using a 1:1 allocation into 2 groups: patients receiving a vitamin E-containing dressing (group 1) and a conventional dressing (group 2). The primary outcomes variable will be occurrence of incisional SSI. Follow-up will be 30 days postoperatively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vitamin E

Trials testing the same drug.

Other recruiting trials for Surgical Site Infection

Currently open trials in the same condition.

Other Hospital General Universitario Elche trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03443141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing